Carlsmed® uses patient data and digital technologies to create optimal surgical plans and personalized aprevo® spine fusion devices for each patient.
Carlsmed® digital technologies help guide preoperative decisions to align surgeon and patient expectations and increase patient satisfaction.
aprevo® was developed to help surgeons achieve the desired correction during surgery. This has been proven to reduce complications and improve outcomes.1,2
1 – Rothenfluh, Euro spine journal 2015
2 – Tempel ZJ, Neurosurgery, 2017
The impact of adult spinal deformity on quality of life exceeds that of arthritis, chronic lung disease, diabetes, and congestive heart failure,1 with procedures for surgical correction expected to more than double in the next 2 decades.2
1. Pillisé, et. al., Impact on health related quality of life of adult spinal deformity… Eur Spine J. 2015;24.
2. Kalakoti, et. al., Forecasting spinal deformity health care burden… Spine Journal 2019, Vol 19, Iss 9.
aprevo® is both an FDA Breakthrough Device and a Medicare Transformative New Device. No other technology available for spine surgery has received this recognition.